Annexon ANNX Stock
Annexon Price Chart
Annexon ANNX Financial and Trading Overview
| Annexon stock price | 3.16 USD |
| Previous Close | 2.34 USD |
| Open | 2.37 USD |
| Bid | 1.7 USD x 200 |
| Ask | 2.85 USD x 200 |
| Day's Range | 2.21 - 2.41 USD |
| 52 Week Range | 1.29 - 7.85 USD |
| Volume | 1.38M USD |
| Avg. Volume | 1.6M USD |
| Market Cap | 254.54M USD |
| Beta (5Y Monthly) | 1.259 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.29 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.6 USD |
ANNX Valuation Measures
| Enterprise Value | 27.93M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.0350876 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.0441045 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.154 |
Trading Information
Annexon Stock Price History
| Beta (5Y Monthly) | 1.259 |
| 52-Week Change | -60.17% |
| S&P500 52-Week Change | 13.16% |
| 52 Week High | 7.85 USD |
| 52 Week Low | 1.29 USD |
| 50-Day Moving Average | 2.31 USD |
| 200-Day Moving Average | 3.79 USD |
ANNX Share Statistics
| Avg. Volume (3 month) | 1.6M USD |
| Avg. Daily Volume (10-Days) | 2.25M USD |
| Shares Outstanding | 109.71M |
| Float | 82.38M |
| Short Ratio | 6.99 |
| % Held by Insiders | 0.56% |
| % Held by Institutions | 102.97% |
| Shares Short | 10.12M |
| Short % of Float | 11.52% |
| Short % of Shares Outstanding | 9.22% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | March 31, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -37.65% |
| Return on Equity (ttm) | -66.13% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -180756992 USD |
| Net Income Avi to Common (ttm) | -167380000 USD |
| Diluted EPS (ttm) | -1.17 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 263.7M USD |
| Total Cash Per Share (mrq) | 2.4 USD |
| Total Debt (mrq) | 28.31M USD |
| Total Debt/Equity (mrq) | 11.61 USD |
| Current Ratio (mrq) | 7.994 |
| Book Value Per Share (mrq) | 2.222 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -139794000 USD |
| Levered Free Cash Flow (ttm) | -71027248 USD |
Profile of Annexon
| Country | United States |
| State | CA |
| City | Brisbane |
| Address | 1400 Sierra Point Parkway |
| ZIP | 94005 |
| Phone | 650 822 5500 |
| Website | https://www.annexonbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 106 |
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Q&A For Annexon Stock
What is a current ANNX stock price?
Annexon ANNX stock price today per share is 3.16 USD.
How to purchase Annexon stock?
You can buy ANNX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Annexon?
The stock symbol or ticker of Annexon is ANNX.
Which industry does the Annexon company belong to?
The Annexon industry is Biotechnology.
How many shares does Annexon have in circulation?
The max supply of Annexon shares is 109.89M.
What is Annexon Price to Earnings Ratio (PE Ratio)?
Annexon PE Ratio is now.
What was Annexon earnings per share over the trailing 12 months (TTM)?
Annexon EPS is -1.29 USD over the trailing 12 months.
Which sector does the Annexon company belong to?
The Annexon sector is Healthcare.
Annexon ANNX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23724.96 USD — |
+0.61
|
9.88B USD — | 23628.82 USD — | 23946.23 USD — | — - | 9.88B USD — |
| US Tech Global Select Market Com NQGS | 11620.1 USD — |
+0.59
|
— — | 11575.56 USD — | 11733.88 USD — | — - | — — |
| US Tech Biotechnology NBI | 5366.46 USD — |
+1.2
|
— — | 5276.16 USD — | 5372.71 USD — | — - | — — |
| US Tech Health Care IXHC | 1115.96 USD — |
+0.87
|
— — | 1099.74 USD — | 1117.62 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}